Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR PR B). The dividend will be paid in shares of Series B stock in an amount per share equal to the quotient of (a) $3.00 divided by (b) 97% of the average of the volume-weighted average price per share of the Series B stock on the New York Stock Exchange for each of the five consecutive trading days ending on the second trading day immediately prior to the record date of the dividend. Alere will pay cash in lieu of any fractional shares resulting from the dividend. The dividend is payable on April 15, 2011 to holders of record of Series B stock at the close of business on April 1, 2011. Such payment will cover the amount of all dividends accrued from January 1, 2011 through March 31, 2011.
Alere i RSV test receives FDA CLIA waiver for detection of RSV infection in children, adults